Valuation: Boston Scientific Corporation

Market Cap 67.64B 59.36B 55.28B 50.85B 95.31B 6,462B 96.95B 656B 257B 3,205B 254B 248B 11,073B P/E 2026 *
16.3x
P/E 2027 * 15.9x
Enterprise Value 74.2B 65.12B 60.64B 55.77B 105B 7,089B 106B 719B 282B 3,516B 279B 273B 12,147B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.05x
Free-Float
84.76%
Yield 2026 *
-
Yield 2027 * -
1 day+2.03%
1 week+7.51%
Current month+8.80%
1 month+6.80%
3 months-20.56%
6 months-50.49%
Current year-51.30%
1 week 42.5
Extreme 42.5
47.16
1 month 42.2
Extreme 42.2
47.16
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
7/1/26 A Fiscal year

Chief Financial Officer

5,184 0.0004%
5/28/26 A Don

Chief Executive Officer

-386,755 0.0261%
5/20/26 A Buy

Director

1,770 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.05%+7.51%-56.13%-10.17% 67.64B
+1.90%+9.31%+17.98%+1.84% 208B
+1.55%+11.33%-1.80%-23.37% 138B
+2.32%+4.30%-26.08%+11.82% 126B
+0.71%-0.69%+6.98%+0.27% 47.81B
+1.01%+4.09%-24.96%-31.74% 45.03B
+1.26%+4.92%+16.61%+10.59% 38.94B
+2.87%+3.86%+26.26%+33.59% 36.45B
+2.72%+6.21%-23.97%-6.82% 29.29B
+1.54%-0.24%+74.80%-0.19% 28.67B
Average +1.78%+1.32%+0.97%-1.42% 76.6B
Weighted average by Cap. +1.83%+1.49%-1.75%-2.65%

Financials

2026 *2027 *
Net sales 21.57B 18.93B 17.62B 16.21B 30.39B 2,060B 30.91B 209B 81.84B 1,022B 80.96B 79.21B 3,530B 23.29B 20.44B 19.03B 17.51B 32.82B 2,225B 33.38B 226B 88.39B 1,104B 87.44B 85.55B 3,813B
Net income 3.94B 3.45B 3.22B 2.96B 5.55B 376B 5.64B 38.16B 14.94B 186B 14.78B 14.46B 644B 4.11B 3.61B 3.36B 3.09B 5.8B 393B 5.9B 39.88B 15.61B 195B 15.44B 15.11B 673B
Net Debt 6.56B 5.76B 5.36B 4.93B 9.24B 627B 9.4B 63.58B 24.89B 311B 24.62B 24.09B 1,074B 3.43B 3.01B 2.8B 2.57B 4.83B 327B 4.91B 33.21B 13B 162B 12.86B 12.58B 561B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
28/07/26 $46.50 +2.18% 11,633,281
27/07/26 $45.51 +2.85% 20,044,682
24/07/26 $44.25 +1.54% 20,689,854
23/07/26 $43.58 +1.42% 16,535,740
22/07/26 $42.97 -0.51% 11,201,174
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
30
Last Close Price
45.51USD
Average target price
72.25USD
Spread / Average Target
+58.76%

Quarterly revenue - Rate of surprise